|
Editor's Note:
At this point, we pause to reflect on some of the healthcare events that we attended. In January we started the 2009 by attending the JP Morgan Healthcare Conference. We look forward to attending JP Morgan's upcoming 2010 event.
We attended a meeting in the Spring that discussed topics involving commercializing stem cell research and Integrating IT in pharma R&D. CHI's Molecular Medicine Conference was well attended big event.
In June, we attended CHI's Genomic Tools Conference. In August we attended IDG's Next Gen Data Center/ Open Source Conference and wondered where Linux World went. It was not well attended -- probably due to the bad economy.
In October we attended the BIO Investor Forum, a meeting which revealed some new biotech companies to watch in 2010.
We enjoyed the lively discussions that these meetings produced. These events provided signs of opportunity verses a backdrop of a down economy, a new president, progress in healthcare and other changes to come. The contacts and information from these events helped us publish new research reports on topics including biochips, biomarkers, pharma IT, stem cell R&D and so on.
- Jay Myers, Editor and Publisher
|
|
